Sutro Biopharma Inc (STRO)
3.995
-0.16
(-3.73%)
USD |
NASDAQ |
May 17, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Cash from Investing (TTM): -7.27M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -7.27M |
December 31, 2023 | -3.924M |
September 30, 2023 | -18.29M |
June 30, 2023 | 17.69M |
March 31, 2023 | -0.553M |
December 31, 2022 | -35.02M |
September 30, 2022 | 23.64M |
June 30, 2022 | 99.44M |
March 31, 2022 | 57.40M |
December 31, 2021 | -97.32M |
September 30, 2021 | -102.29M |
Date | Value |
---|---|
June 30, 2021 | -99.75M |
March 31, 2021 | -162.76M |
December 31, 2020 | 0.604M |
September 30, 2020 | -7.261M |
June 30, 2020 | 2.255M |
March 31, 2020 | 68.58M |
December 31, 2019 | -51.13M |
September 30, 2019 | -57.05M |
June 30, 2019 | -148.68M |
March 31, 2019 | -157.90M |
December 31, 2018 | -80.19M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-162.76M
Minimum
Mar 2021
99.44M
Maximum
Jun 2022
-26.08M
Average
-7.266M
Median
Cash from Investing (TTM) Benchmarks
AnaptysBio Inc | 127.97M |
ABVC BioPharma Inc | -0.3602M |
Reviva Pharmaceuticals Holdings Inc | -- |
Flora Growth Corp | -0.234M |
Journey Medical Corp | 0.00 |